Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia

This study has been completed.
Information provided by (Responsible Party):
University of Aarhus Identifier:
First received: April 21, 2010
Last updated: August 5, 2013
Last verified: August 2013
The purpose of this study is to estimate the acute effect of hyperglycemia on Very-Low-Density-Lipoprotein-triglyceride(VLDL-TG) secretion.

Condition Intervention
Type 1 Diabetes
Other: Hyperglycemia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia

Resource links provided by NLM:

Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) secretion [ Time Frame: 8 hours ]
    Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) kinetics over a single study day

Biospecimen Retention:   Samples With DNA
Blood Samples

Enrollment: 8
Study Start Date: April 2012
Study Completion Date: April 2013
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Type 1 diabetes Other: Hyperglycemia
Hyperglycemia with a blood glucose of 15 mmol/L


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Type 1 diabetics

Inclusion Criteria:

  1. Type 1 diabetes
  2. Age 18-50 years

Exclusion Criteria:

  1. Smoking
  2. Alcohol abuse
  3. Use of medications (except insulin in diabetics)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01178957

Department of Endocrinology MEA, Aarhus Hospital
Aarhus C, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: University of Aarhus Identifier: NCT01178957     History of Changes
Other Study ID Numbers: ES-0004
Study First Received: April 21, 2010
Last Updated: August 5, 2013

Keywords provided by University of Aarhus:
Type 1 diabetes

Additional relevant MeSH terms:
Diabetes Mellitus, Type 1
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases processed this record on April 28, 2017